AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed'
The companies have discussed a potential merger over several months, reports say.
The companies have discussed a potential merger over several months, reports say. This story matters for Finance & Markets readers tracking fund. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. FundNews curates and briefs the finance & markets stories that matter. Our editorial policy →